344 related articles for article (PubMed ID: 16127012)
1. Pathogenesis of rheumatoid arthritis: targeting cytokines.
Zwerina J; Redlich K; Schett G; Smolen JS
Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
[TBL] [Abstract][Full Text] [Related]
2. Biological agents in rheumatoid arthritis.
Shankar S; Handa R
J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
[TBL] [Abstract][Full Text] [Related]
3. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
4. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
Meyer O
Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
[TBL] [Abstract][Full Text] [Related]
5. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
6. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
Voll RE; Kalden JR
Ann N Y Acad Sci; 2005 Jun; 1051():799-810. PubMed ID: 16127017
[TBL] [Abstract][Full Text] [Related]
7. Immunological therapies for rheumatoid arthritis.
Edwards CJ
Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in the pathogenesis of rheumatoid arthritis.
Feldmann M; Maini RN
Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
Dinarello CA
Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950
[TBL] [Abstract][Full Text] [Related]
10. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
11. Molecular therapeutic targets in rheumatoid arthritis.
Sacre SM; Andreakos E; Taylor P; Feldmann M; Foxwell BM
Expert Rev Mol Med; 2005 Aug; 7(16):1-20. PubMed ID: 16117838
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
Okada Y; Nawata M; Tanaka Y
Clin Calcium; 2009 Aug; 19(8):1186-90. PubMed ID: 19638703
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and anti-cytokine strategies in inflammatory reaction modulation.
Delannoy I; Lekeux P; Miossec P
Vet Res; 1993; 24(6):449-67. PubMed ID: 8111428
[TBL] [Abstract][Full Text] [Related]
14. The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells.
Musacchio E; Valvason C; Botsios C; Ostuni F; Furlan A; Ramonda R; Modesti V; Sartori L; Punzi L
J Rheumatol; 2009 Aug; 36(8):1575-9. PubMed ID: 19567627
[TBL] [Abstract][Full Text] [Related]
15. New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis.
Breedveld F
Eur Cytokine Netw; 1998 Sep; 9(3):233-8. PubMed ID: 9831171
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
17. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
18. [Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].
Tanaka Y
Clin Calcium; 2010 Oct; 20(10):1545-52. PubMed ID: 20890038
[TBL] [Abstract][Full Text] [Related]
19. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
[TBL] [Abstract][Full Text] [Related]
20. New cytokine targets in inflammatory rheumatic diseases.
Connell L; McInnes IB
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
